| Excerpt | Relevance | Reference |
|---|
| "The objective of this study was to determine the prevalence of pyridoxine deficiency, measured by pyridoxal phosphate (PLP) levels, in patients admitted to the hospital with established (benzodiazepine-resistant) status epilepticus (SE) (eSE) and to compare to three control groups: intensive care unit (ICU) patients without SE (ICU-noSE), non-ICU inpatients without SE (non-ICU), and outpatients with or without a history of epilepsy (outpatient)." | 8.31 | Association of Serum Pyridoxal Phosphate Levels with Established Status Epilepticus. ( Blodgett, C; Boudesseul, J; Bruzzone, MJ; Hianik, R; Hirsch, LJ; Jadav, R; Liu, C; Meeker, R; Olm-Shipman, C; Patel, P; Rubinos, C; Tsai, C; Wilson, SE; Zhu, H, 2023) |
| "The objective of this study was to determine the prevalence of pyridoxine deficiency, measured by pyridoxal phosphate (PLP) levels, in patients admitted to the hospital with established (benzodiazepine-resistant) status epilepticus (SE) (eSE) and to compare to three control groups: intensive care unit (ICU) patients without SE (ICU-noSE), non-ICU inpatients without SE (non-ICU), and outpatients with or without a history of epilepsy (outpatient)." | 4.31 | Association of Serum Pyridoxal Phosphate Levels with Established Status Epilepticus. ( Blodgett, C; Boudesseul, J; Bruzzone, MJ; Hianik, R; Hirsch, LJ; Jadav, R; Liu, C; Meeker, R; Olm-Shipman, C; Patel, P; Rubinos, C; Tsai, C; Wilson, SE; Zhu, H, 2023) |